Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mexican labs flaunt ISO 15189 accreditation "first":

This article was originally published in Clinica

Executive Summary

Mexican pathology and diagnostic services firm Grana SA/ Laboratorios Dr Moreira recently gained international standard ISO 15189:2003 accreditation for a wide range of services. The areas specifically covered by its certificate are: biochemistry, endocrinology, lipids, serology, immunology, haematology, urinalysis, microbiology, parasitology, cytology and histopathology. The Monterrey, Nuevo Leon laboratories also offer testing in genetics, bacterology and nuclear medicine, among other things - totalling almost 1,100 types of tests, according to its website ( The accreditation by the UK's leading body in this area (UKAS), in partnership with the UK's Clinical Pathology Accreditation (CPA), has been billed as a milestone in the provision of such services internationally.

You may also be interested in...

Interview: Arvelle Aims To Be Major Player In CNS

The Swiss biotech's focal-onset seizure therapy, which is licensed from South Korea's SK and is already approved in the US, could have potential in indications beyond epilepsy, Arvelle's CEO tells Scrip.

The Factory Floor: Biocon Celebrates Malaysian Insulin Plant Clearance

Biocon has reported FDA clearance for its Malaysian insulin facility, while Lupin and Xellia have also received plant approvals. Meanwhile, Alembic has seen mixed fortunes, receiving both Form 483 observations and an EIR.

Lannett Rolls Out US Adderall XR Rival

Lannett has begun marketing a US rival to Adderall XR through a partnership with Elite and SunGen. But the product will face competition from a range of other generics.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts